DHEA-S and Aging: What This Hormone Tells You About Biological Age

You track your cholesterol, monitor your glucose, maybe even check your vitamin D. But there's a hormone most people have never heard of that declines more predictably with age than almost any other biomarker in your body. By the time you're 70, your levels may be just 10 to 20 percent of what they were at 25. The question isn't whether DHEA-S drops as you age (Nature Aging: DHEA-S biogenesis implicated in primate adrenal aging). It's whether that drop matters, and what it tells you about how well you're aging at a cellular level (Endotext: adrenal androgens and aging) (DHEA-S as an endocrine marker of aging).

Key Takeaways

• DHEA-S declines approximately 2 percent per year after age 30.
• Low DHEA-S correlates with increased cardiovascular mortality and frailty risk (Harvard Health on DHEA supplement safety and effectiveness).
• The decline reflects adrenal aging, not just chronological time passing.
• DHEA-S levels vary widely between individuals of the same age.
• Supplementation evidence remains mixed, with stronger data in specific populations.
• DHEA-S sits at the intersection of multiple aging hallmarks.
• Tracking DHEA-S over time provides more insight than a single measurement (Cleveland Clinic on the DHEA-S test).

What DHEA-S Actually Measures in Your Body

Dehydroepiandrosterone sulfate is the most abundant steroid hormone circulating in your bloodstream. It's produced primarily in the zona reticularis of your adrenal glands, the same tissue that makes cortisol. Unlike cortisol, which fluctuates throughout the day in response to stress, meals, and sleep, DHEA-S remains relatively stable. That stability makes it a useful marker. A single blood draw captures your baseline production capacity without the noise of circadian rhythm or acute stress response.

DHEA-S serves as a precursor to both androgens and estrogens. Your tissues convert it locally into testosterone, estradiol, and other active hormones depending on what they need. This decentralized production system means DHEA-S functions less like a direct signal and more like a reservoir. When that reservoir shrinks, your tissues lose flexibility in how they respond to metabolic and hormonal demands.

The decline begins around age 30 and continues linearly:

• Peak levels occur in your mid-20s, ranging between 1.33 and 7.78 ng/mL.
• By age 40, that range drops to 0.63 to 4.7 ng/mL.
• By 70 to 80, many people retain only 10 to 20 percent of their youthful levels.
• This pattern holds across populations and is one of the most consistent age-related hormonal changes in humans.

The mechanism driving this decline involves thinning of the adrenal zona reticularis, the specific layer responsible for DHEA-S synthesis. As that tissue atrophies, production capacity falls.

How DHEA-S Decline Connects to the Hallmarks of Aging

The drop in DHEA-S doesn't happen in isolation. It reflects and amplifies several core aging processes. The adrenal zona reticularis thins with age, a form of tissue-specific stem cell exhaustion. The cells that replenish DHEA-S-producing tissue lose their regenerative capacity, and the tissue itself becomes less metabolically active. This is cellular senescence playing out in a specific endocrine context.

Low DHEA-S also correlates with chronic low-grade inflammation (or inflammaging). Studies show that individuals with lower DHEA-S levels have higher circulating markers of systemic inflammation, including C-reactive protein and interleukin-6. The directionality isn't entirely clear, but the association is consistent. DHEA-S appears to have anti-inflammatory properties, and when levels fall, the inflammatory tone rises. This creates a feedback loop where inflammation accelerates tissue aging, which further suppresses DHEA-S production.

Mitochondrial dysfunction is another hallmark linked to DHEA-S decline:

• DHEA-S influences mitochondrial biogenesis and energy production in multiple tissues.
• When levels drop, cells lose some capacity to generate ATP efficiently.
• This shows up as reduced physical resilience, slower recovery from exertion, and decreased muscle mass.
• The connection between DHEA-S and muscle function is particularly strong in older adults, where low levels predict sarcopenia and frailty.

Deregulated nutrient sensing also plays a role. DHEA-S interacts with insulin signaling pathways and influences how cells respond to glucose. Lower DHEA-S is associated with insulin resistance and higher fasting insulin levels, both markers of metabolic aging. The hormone also modulates the hypothalamic-pituitary-adrenal axis, affecting how your body responds to stress over time. Chronic stress accelerates DHEA-S decline, and low DHEA-S reduces stress resilience, creating another reinforcing loop.

What Drives DHEA-S Levels Higher or Lower

Chronological age is the dominant driver, but it's not the only one. Chronic stress accelerates the decline. Prolonged elevation of cortisol (the primary stress hormone) suppresses DHEA-S production. The adrenal glands prioritize cortisol synthesis under sustained stress, and DHEA-S production takes a back seat. This is why people with chronic stress-related conditions often have DHEA-S levels lower than expected for their age.

Sleep quality matters. Growth hormone (which is secreted during deep sleep) supports adrenal function. Poor sleep disrupts this process and contributes to accelerated adrenal aging. Studies show that individuals with chronic sleep deprivation have lower DHEA-S levels independent of age.

Body composition plays a role. Higher visceral fat is associated with lower DHEA-S, likely through inflammatory pathways. Adipose tissue (especially visceral fat) secretes pro-inflammatory cytokines that suppress adrenal steroid production. Conversely, maintaining lean muscle mass correlates with better preservation of DHEA-S levels over time.

Exercise has mixed effects:

• Moderate aerobic exercise and resistance training appear to support DHEA-S production, possibly through improved mitochondrial function and reduced systemic inflammation.
• Chronic overtraining without adequate recovery can suppress DHEA-S, similar to how it suppresses other anabolic hormones.
• The dose-response curve is not linear.

Nutritional status influences DHEA-S indirectly. Deficiencies in key micronutrients like zinc, magnesium, and B vitamins impair adrenal function. Chronic caloric restriction (while beneficial for some aging markers) can lower DHEA-S if taken to extremes. The adrenal glands require adequate substrate to synthesize steroid hormones, and severe energy deficit compromises that capacity.

Why Two People the Same Age Have Different DHEA-S Levels

Genetics account for a significant portion of the variability. Twin studies suggest that heritability of DHEA-S levels is around 50 to 60 percent. Specific gene variants influence adrenal enzyme activity, particularly those involved in steroid synthesis pathways. Some people are genetically predisposed to maintain higher DHEA-S into older age, while others decline more rapidly.

Baseline adrenal reserve varies. Not everyone starts with the same peak levels in their 20s. Those who begin with higher levels have more room to decline before reaching clinically low thresholds. This is similar to the concept of cognitive reserve in brain aging. A larger starting reserve provides a buffer against age-related decline.

Cumulative stress exposure matters more than acute stress. Allostatic load (the wear and tear from repeated stress responses) predicts DHEA-S decline better than any single stressor. Early life adversity, chronic work stress, and prolonged caregiving responsibilities all contribute to accelerated adrenal aging. The body keeps score, and DHEA-S reflects that cumulative burden.

Hormonal milieu influences DHEA-S differently across sexes:

• Women experience a sharper drop in DHEA-S during and after menopause, likely due to the loss of ovarian estrogen, which supports adrenal function.
• Men experience a more gradual decline, though testosterone levels also influence DHEA-S production.
• The interplay between sex hormones and adrenal steroids creates individual variation in how aging unfolds hormonally.

Metabolic health is a major modifier. Individuals with insulin resistance, metabolic syndrome, or type 2 diabetes tend to have lower DHEA-S for their age. The relationship is bidirectional: low DHEA-S contributes to metabolic dysfunction, and metabolic dysfunction accelerates DHEA-S decline. Breaking that cycle requires addressing both sides of the equation.

What the Research Actually Shows About DHEA-S and Health Outcomes

Mortality and cardiovascular outcomes

The association between low DHEA-S and mortality is one of the most replicated findings in aging research. Multiple cohort studies show that individuals in the lowest tertile of DHEA-S have significantly higher all-cause mortality compared to those in the highest tertile. In one study of postmenopausal women, those with the lowest DHEA-S had a 17 percent six-year mortality rate compared to 8 percent in the highest group. The effect persists after adjusting for age, suggesting DHEA-S captures something about biological aging beyond chronological time.

Cardiovascular outcomes follow a similar pattern. Lower DHEA-S predicts increased risk of cardiovascular disease mortality, heart failure progression, and adverse events in patients with existing heart disease. The mechanism likely involves multiple pathways: inflammation, endothelial dysfunction, insulin resistance, and altered lipid metabolism. DHEA-S appears to have cardioprotective effects, and when levels fall, cardiovascular risk rises.

Frailty and physical function

Frailty is strongly linked to low DHEA-S. Frailty is a clinical syndrome characterized by weakness, slow walking speed, low physical activity, exhaustion, and unintentional weight loss. It's distinct from disability but predicts it. Studies show that older adults with low DHEA-S are significantly more likely to develop frailty, particularly the mobility subtype. The connection runs through muscle mass, mitochondrial function, and inflammatory tone, all of which are influenced by DHEA-S.

Cognitive decline and bone health

Cognitive decline shows weaker but still present associations. Some studies link low DHEA-S to increased risk of dementia and faster cognitive decline, while others find no relationship. The inconsistency may reflect differences in study populations, follow-up duration, or the specific cognitive domains assessed. DHEA-S does cross the blood-brain barrier and has neuroprotective properties in animal models, but translating that to human cognitive outcomes has proven difficult.

Bone health is another area with mixed evidence. Some studies show that low DHEA-S predicts lower bone mineral density and higher fracture risk, particularly in women. Others find no association. The variability likely reflects the complex interplay between DHEA-S, sex hormones, and bone metabolism. DHEA-S is converted to estrogen and testosterone in bone tissue, and those local conversions matter more than circulating DHEA-S levels alone.

What the Evidence Shows About DHEA Supplementation

The supplementation literature is large but inconsistent. DHEA supplements raise circulating DHEA-S levels reliably. That part is not in question. The question is whether raising levels translates to meaningful health benefits.

For bone density, the evidence leans slightly positive in older women with low baseline DHEA-S. A systematic review found modest improvements in bone mineral density with 50 mg daily supplementation, but the effect size was small and not seen in men. For muscle strength and physical function, results are mixed. Some trials show improvements in lean mass and grip strength, particularly in older adults with very low baseline levels. Others show no benefit.

For cardiovascular risk factors, the data do not support routine supplementation:

• Trials have not shown consistent improvements in lipid profiles, blood pressure, or inflammatory markers.
• One meta-analysis found that DHEA supplementation had no significant effect on cardiovascular outcomes compared to placebo.

For cognitive function, the evidence is weak. Multiple trials in middle-aged and older adults found no benefit of DHEA supplementation on memory, executive function, or mood. The one exception is a subset of individuals with depression and low baseline DHEA-S, where some studies show modest mood improvement.

The dose matters. Most studies use 25 to 50 mg daily. Higher doses raise testosterone and estradiol levels more substantially, which can cause side effects including acne, hair growth, and voice changes in women. Lower doses may not raise DHEA-S enough to produce measurable effects. The therapeutic window is narrow, and individual responses vary widely.

The quality of evidence is limited by short trial durations. Most studies run 6 to 12 months. Whether long-term supplementation over years or decades affects aging trajectories is unknown. The longest trials show that benefits (when present) plateau after the first few months. This suggests that simply raising DHEA-S levels does not reverse the underlying aging processes that caused the decline in the first place.

Measuring DHEA-S to Track Your Biological Aging Trajectory

A single DHEA-S measurement tells you where you stand relative to age-matched reference ranges. That's useful, but limited. The real value comes from tracking changes over time. DHEA-S declines predictably, so the rate of decline matters more than the absolute number. Someone whose levels drop faster than expected for their age is aging faster biologically. Someone whose levels hold steady or decline slowly is aging more slowly.

Testing DHEA-S is straightforward:

• It's a single blood draw, and levels are stable throughout the day, so timing doesn't matter.
• Unlike cortisol or testosterone, you don't need to test at a specific time of morning.
• That makes it easier to track consistently.

Interpreting results requires context. Reference ranges are broad and age-stratified. For adults aged 30 to 39, typical ranges are 40 to 325 µg/dL. For ages 50 to 59, they drop to 15 to 170 µg/dL. Being in the lower half of the range for your age suggests accelerated adrenal aging. Being in the upper half suggests better preservation of adrenal function.

DHEA-S should be interpreted alongside other markers of metabolic and hormonal health. Low DHEA-S combined with high fasting insulin, elevated hsCRP, and poor lipid markers paints a picture of accelerated biological aging. Low DHEA-S with otherwise favorable metabolic markers is less concerning and may simply reflect genetic variation.

Tracking DHEA-S over years provides insight into how interventions are working. If you implement changes to reduce chronic stress, improve sleep, or improve body composition, you should see stabilization or even modest improvement in DHEA-S levels. If levels continue to drop rapidly despite those efforts, it signals that something else is driving accelerated aging, and further investigation is warranted.

Using DHEA-S as Part of a Comprehensive Longevity Strategy

DHEA-S is one piece of a larger puzzle. It reflects adrenal aging, hormonal balance, inflammatory tone, and metabolic health. Tracking it alongside markers like ApoB, HbA1c, fasting insulin, and ferritin gives you a more complete picture of how you're aging at a biological level. Superpower's 100+ biomarker panel includes DHEA-S as part of a comprehensive assessment designed to identify where your aging trajectory is accelerating and where it's holding steady. Measuring what matters, over time, is how you turn longevity science into actionable insight.